Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)

SHE:301617 Revenue

Shandong Boyuan Pharmaceutical & Chemical had revenue of 381.40M CNY in the quarter ending September 30, 2026, with 16.75% growth. This brings the company's total for the last twelve months to 1.55B, up 10.95% year-over-year. In the year 2025, Shandong Boyuan Pharmaceutical & Chemical had annual revenue of 1.46B with 10.30% growth. That makes Shandong Boyuan Pharmaceutical & Chemical the 16,431st largest company in the world by revenue and 2,977th in China.

• Revenue (ttm): 1.55B
• Revenue Growth: +10.95%
• P/S Ratio: 5.05
• Revenue / Employee: 2.07M
• Employees: 748
• Market Cap: 7.80B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 1.45B 98.8%
• Overseas 17.25M 1.2%

Fiscal year ended Dec 31, 2025 See the full SHE:301617 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.46B	136.80M	10.30%
Dec 31, 2024	1.33B	302.73M	29.53%
Dec 31, 2023	1.03B	226.68M	28.39%
Dec 31, 2022	798.47M	274.10M	52.27%
Dec 31, 2021	524.37M	144.93M	38.20%

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error